Sort
51,593 grants matching “hepatitis”
Role and mechanisms of excretion in manganese neurotoxicity
$580,914Somshuvra Mukhopadhyay · University Of Texas At Austin · R01 · FY2022 · ES
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
$580,907Shruti H Mehta · Johns Hopkins University · R01 · FY2012 · DA
HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids
$580,906Pedro Mateu-Gelabert · National Development And Research Institutes, Inc. · R01 · FY2015 · DA
GENE THERAPY FOR HEMOPHILIA A AND B
$580,809Salk Institute For Biological Studies · R01 · FY2002 · HL
Neuropathogenesis of Rift Valley fever virus
$580,741Anita K McElroy · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
High Density Lipoprotein Biogenesis and Speciation
$580,616Henry J. Pownall · Methodist Hospital Research Institute · R01 · FY2019 · HL
High Density Lipoprotein Biogenesis and Speciation
$580,616Henry J. Pownall · Methodist Hospital Research Institute · R01 · FY2018 · HL
High Density Lipoprotein Biogenesis and Speciation
$580,616Henry J. Pownall · Methodist Hospital Research Institute · R01 · FY2017 · HL
Investigating Syndecan-1 in Hepcidin Regulation and Iron Metabolism
$580,581Philip Gordts · University Of California, San Diego · R01 · FY2024 · DK
CVD in American Indians Genetics Center
$580,560Shelley A Cole · Texas Biomedical Research Institute · R01 · FY2015 · HL
Nano-carrier Formulations for Targeted Drug Delivery and Malaria Radical Cure
$580,539Babu L Tekwani · University Of Mississippi · R01 · FY2017 · AI
Metabolic control of gut-brain axis in Familial Dysautonomia
$580,528Frances Lefcort · Montana State University - Bozeman · R01 · FY2021 · DK
Metabolic control of gut-brain axis in Familial Dysautonomia
$580,528Valerie Copie · Montana State University - Bozeman · R01 · FY2022 · DK
Metabolic control of gut-brain axis in Familial Dysautonomia
$580,528Frances Lefcort · Montana State University - Bozeman · R01 · FY2019 · DK
HCV Infection--Risk Factors for Progression
$580,526Harvard University (Sch Of Public Hlth) · R01 · FY2005 · CA
Project 1: Cirrhosis-stroma-directed HCC chemoprevention with EGFR inhibition
$580,523Yujin Hoshida · Ut Southwestern Medical Center · P50 · FY2025 · CA
Systems genetics approaches to bile acid metabolisms
$580,506Karen Reue · University Of California Los Angeles · P01 · FY2017 · HL
Systems genetics approaches to bile acid metabolisms
$580,506Karen Reue · University Of California Los Angeles · P01 · FY2019 · HL
Systems genetics approaches to bile acid metabolisms
$580,506Karen Reue · University Of California Los Angeles · P01 · FY2018 · HL
Predicting outcomes in nonalcoholic steatohepatitis with advanced fibrosis
$580,486Arun J Sanyal · Virginia Commonwealth University · R01 · FY2023 · DK
Hepatocyte-derived extracellular vesicles in alcoholic liver disease
$580,403Ariel Feldstein · University Of California, San Diego · R01 · FY2021 · AA
Social determinants of fatty liver disease and its racial/ethnic disparities: The Multi-Ethnic Study of Atherosclerosis
$580,398Mariana Lazo Elizondo · Drexel University · R01 · FY2025 · DK
Integration of Evolution to Avoid Resistance in Structure Based Drug Design
$580,386Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · GM
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance
$580,341Mariana Nikolova-Karakashian · University Of Kentucky · R01 · FY2024 · DK
Modulation of internal ribosome entry by ribosomal protein RPS25
$580,275Peter Sarnow · Stanford University · R01 · FY2018 · AI